Teijin Limited (TINLF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Teijin Limited (TINLF) trades at $9.51 with AI Score 41/100 (Grade C). Teijin Limited is a diversified global enterprise founded in Tokyo, Japan, in 1918, operating across advanced materials, healthcare, and IT sectors. Market cap: $1.83B, Sector: Industrials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for TINLF: TINLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TINLF against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TINLF: the 1 perspectives are evenly split.
How is this calculated? →Teijin Limited (TINLF) Industrial Operations Profile
Teijin Limited, established in 1918 in Tokyo, Japan, is a diversified global enterprise specializing in advanced materials like aramid and carbon fibers, healthcare solutions including pharmaceuticals and medical devices, and IT services. The company addresses global challenges through its engineering expertise, serving automotive, aerospace, and medical sectors worldwide.
What Is the Investment Thesis for TINLF?
Teijin Limited presents a diversified investment profile through its integrated operations in advanced materials, healthcare, and IT, offering exposure to multiple growth vectors. The company's strong position in high-performance materials, particularly carbon and aramid fibers, aligns with increasing demand for lightweight solutions in automotive and aerospace sectors, driven by fuel efficiency and electrification trends. Its healthcare segment, focused on pharmaceuticals and medical devices for conditions like bone and joint and respiratory diseases, benefits from an aging global demographic and rising healthcare needs. Despite a current Profit Margin of -10.1%, indicating operational challenges, the company maintains a Gross Margin of 18.5%. The dividend yield of 3.05% offers income potential, while a Beta of 0.30 suggests lower volatility relative to the broader market. The company's strategic focus on addressing global issues through its engineering expertise could unlock long-term value, though its OTC Other tier listing introduces liquidity and disclosure risks that warrant careful consideration by institutional investors.
Based on FMP financials and quantitative analysis
TINLF Key Highlights
- Market Capitalization stands at $1.83 billion, reflecting the company's overall valuation in the market.
- A negative Profit Margin of -10.1% indicates the company is currently operating at a loss, requiring scrutiny of its profitability drivers.
- Gross Margin of 18.5% suggests a solid base level of profitability from its core operations before accounting for operating expenses.
- The company exhibits a Dividend Yield of 3.05%, providing a return to shareholders despite current unprofitability.
- A Beta of 0.30 indicates that Teijin Limited's stock price has historically been less volatile than the overall market.
Who Are TINLF's Competitors?
TINLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| KBDCF Kingboard Holdings Limited | $11.85 | -23.56% | $13.29B | 49 |
| CRESY Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria | $11.05 | +0.36% | $716.86M | 64 |
| RSDEF Ramsdens Holdings PLC | $2.39 | +0.00% | $78.15M | 59 |
| MPCFF Metro Pacific Investments Corporation | $0.05 | +0.00% | $1.43B | 58 |
| FIP FTAI Infrastructure Inc. | $4.43 | -0.23% | $523.46M | 57 |
| CODI Compass Diversified (CODI) | $10.26 | -3.30% | $771.92M | 48 |
| UMCN UMC, Inc. | $0.06 | -0.17% | $39.36M | 48 |
| KTERF Keio Corporation | $4.49 | +0.00% | $2.61B | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TINLF's Key Strengths?
- Diversified global operations across advanced materials, healthcare, and IT sectors.
- Strong expertise in high-performance materials like aramid and carbon fibers, crucial for modern industries.
- Comprehensive healthcare portfolio including pharmaceuticals and medical devices.
- Long operational history since 1918, indicating resilience and experience.
- Strategic focus on addressing global challenges through engineering solutions.
What Are TINLF's Weaknesses?
- Current negative Profit Margin of -10.1% indicates unprofitability.
- Trading on the OTC Other tier, potentially limiting liquidity and investor access.
- Complexity of managing a highly diversified conglomerate with varied market dynamics.
- Reliance on global economic conditions impacting industrial and healthcare demand.
- Unknown disclosure status on OTC markets, potentially hindering transparency.
What Could Drive TINLF Stock Higher?
- Increased global adoption of lightweight materials in automotive and aerospace industries, driving demand for Teijin's advanced composites and fibers.
- Continued growth in the global healthcare market, particularly for solutions addressing aging populations, benefiting Teijin's pharmaceuticals and medical devices segment.
- Successful commercialization and wider adoption of Teijin's IT solutions, such as Recopic RFID technology, enhancing revenue from industrial efficiency services.
- Strategic initiatives focused on sustainability and environmental solutions, potentially opening new markets and partnerships for Teijin's engineering expertise.
What Are the Key Risks for TINLF?
- Financial-distress signal — its Altman Z-Score of 1.16 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-22.5%) — the business is not currently generating profit on shareholder capital.
- The company's current negative Profit Margin of -10.1% indicates persistent unprofitability, posing a risk to sustained financial health.
- Limited liquidity and transparency associated with trading on the OTC Other tier may deter institutional investors and lead to higher price volatility.
- Intense competition across Teijin's diversified segments, including advanced materials, healthcare, and IT, could pressure market share and profitability.
- Fluctuations in global economic conditions and raw material prices could negatively impact the demand for industrial materials and the cost of production.
- Regulatory changes in the pharmaceutical and medical device sectors, or environmental regulations, could impose additional compliance costs or restrict market access.
What Are the Growth Opportunities for TINLF?
- **Expansion in Lightweight Materials for Automotive and Aerospace:** The increasing global demand for lightweight materials in the automotive and aerospace industries presents a significant growth opportunity for Teijin. As manufacturers strive for enhanced fuel efficiency, reduced emissions, and improved performance, the adoption of advanced composites like carbon fiber reinforced plastics (CFRP) and glass fiber reinforced plastics (GFRP) is accelerating. Teijin's expertise in these materials, particularly for structural components, positions it to capture a larger share of this market, which is projected to grow substantially over the next decade. This trend is further amplified by the shift towards electric vehicles, where weight reduction is crucial for battery range and performance.
- **Healthcare Solutions for Aging Populations:** Teijin's comprehensive healthcare portfolio, including pharmaceuticals for bone and joint, respiratory, and cardiovascular diseases, alongside medical devices for home oxygen therapy and rehabilitation, is well-aligned with the global demographic trend of an aging population. As the elderly population grows, so does the prevalence of chronic conditions and the need for home-based care solutions. The market for these specialized pharmaceuticals and medical devices is expanding, offering Teijin a sustained growth trajectory by providing essential products and services that improve quality of life and support independent living for seniors.
- **Leveraging IT Solutions for Industrial Efficiency:** The company's IT solutions, such as Recopic RFID technology for inventory management, represent a growth opportunity in the broader industrial efficiency and supply chain optimization market. As businesses increasingly adopt digital transformation strategies, there is a rising demand for smart solutions that enhance operational visibility, reduce waste, and improve logistics. Teijin can expand the application of its RFID and other IT capabilities to various industrial sectors, offering tailored solutions that drive productivity and cost savings for clients. This segment benefits from the ongoing digitalization of manufacturing and retail processes.
- **Sustainable Solutions for Environmental Challenges:** Teijin's commitment to leveraging its engineering expertise to address global issues like environmental pollution and energy supply stability opens avenues for growth in the sustainability sector. This includes developing materials and technologies that contribute to a circular economy, such as advanced recycling processes for plastics, or solutions that improve energy efficiency in industrial applications. The market for environmentally friendly products and processes is driven by stringent regulations and growing corporate social responsibility, providing Teijin with opportunities to innovate and commercialize solutions that meet these evolving demands, potentially securing long-term contracts with eco-conscious industries.
- **Diversification and Application Expansion of Advanced Fibers:** Beyond traditional automotive and aerospace, Teijin has opportunities to expand the application of its advanced fibers, such as aramid and carbon, into new markets. This could include high-performance protective gear, infrastructure reinforcement, wind energy components, or even consumer electronics. The versatility and superior properties of these materials — including strength, lightweight, and heat resistance — make them suitable for a wide array of specialized applications. By actively researching and developing new uses, Teijin can tap into emerging niche markets and diversify its revenue streams, reducing reliance on any single industry segment and fostering sustained growth.
What Opportunities Does TINLF Have?
- Growing demand for lightweight materials in the automotive and aerospace industries.
- Expansion of healthcare solutions driven by an aging global population and increased health awareness.
- Leveraging IT solutions like RFID for industrial efficiency and supply chain optimization.
- Development and commercialization of sustainable solutions for environmental and energy challenges.
- Geographic expansion and deeper penetration into emerging markets for its diverse product portfolio.
What Threats Does TINLF Face?
- Intense competition across all operating segments from specialized and diversified players.
- Economic downturns impacting industrial production and consumer spending on healthcare.
- Regulatory changes in pharmaceuticals, medical devices, and environmental standards.
- Fluctuations in raw material costs for advanced fibers and composites.
- Technological obsolescence or failure to innovate rapidly enough in fast-evolving sectors.
What Are TINLF's Competitive Advantages?
- Proprietary technology and extensive R&D in advanced materials, particularly aramid and carbon fibers, creating high barriers to entry.
- Diversified business model across materials, healthcare, and IT, reducing reliance on any single market segment.
- Long-standing global presence and established relationships with industrial and healthcare clients.
- Specialized expertise in lightweight composites, critical for high-growth sectors like automotive and aerospace.
- Integrated approach to healthcare, combining pharmaceuticals, medical devices, and functional foods.
What Does TINLF Do?
Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, has evolved into a diversified conglomerate with a significant presence across multiple key sectors including fibers, films, composites, healthcare, and information technology. From its origins, Teijin has consistently focused on innovation and advanced material science. The company's advanced materials portfolio is extensive, encompassing various high-performance fibers such as aramid, carbon, and polyester, which are critical components in numerous industrial applications. Beyond fibers, Teijin also produces specialized films like polycarbonate and high-density polyethylene, alongside resins, molded parts, and additives. A notable area of expertise is lightweight glass and carbon fiber reinforced composites, which are particularly vital for reducing weight and improving efficiency in automotive applications, aligning with global sustainability trends. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint disorders, respiratory illnesses, and cardiovascular diseases. Complementing its pharmaceutical offerings, the company provides a suite of medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders. This healthcare segment also includes orthopedic implants and functional food ingredients, catering to an aging global population and increasing health consciousness. Beyond its core materials and healthcare businesses, Teijin offers IT solutions, exemplified by Recopic, an RFID technology designed for efficient inventory management. The company strategically leverages its extensive engineering expertise to address pressing global issues such as environmental pollution, ensuring energy supply stability, and mitigating challenges associated with an aging workforce population, demonstrating a commitment to broader societal contributions.
What Products and Services Does TINLF Offer?
- Develop and manufacture advanced fibers, including aramid, carbon, and polyester, for various industrial applications.
- Produce specialized films such as polycarbonate and high-density polyethylene, used in electronics and packaging.
- Create resins, molded parts, and additives for diverse manufacturing processes.
- Engineer lightweight glass and carbon fiber reinforced composites, primarily for the automotive sector.
- Research, develop, and market pharmaceuticals for conditions like bone and joint, respiratory, and cardiovascular diseases.
- Provide medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders.
- Offer orthopedic implants and functional food ingredients within its healthcare segment.
- Deliver IT solutions, including RFID technology like Recopic, for inventory management and industrial efficiency.
How Does TINLF Make Money?
- Generates revenue through the sale of high-performance materials, including various fibers, films, resins, and composites, to industrial clients.
- Earns income from the development, manufacturing, and sales of pharmaceuticals and medical devices to healthcare providers and patients.
- Provides IT solutions and services, such as RFID systems, to businesses seeking improved operational efficiency and inventory management.
- Leverages its engineering expertise to develop and commercialize solutions addressing environmental and energy challenges, potentially through project-based contracts or specialized product sales.
What Industry Does TINLF Operate In?
Teijin Limited operates within the broad Industrials sector, specifically categorized under Conglomerates, positioning it among companies with diverse business interests. The global industrials sector is characterized by ongoing demand for advanced materials, technological innovation, and solutions addressing environmental and demographic shifts. Teijin's focus on high-performance materials like carbon and aramid fibers places it in a competitive landscape driven by innovation in automotive, aerospace, and electronics. The healthcare segment, encompassing pharmaceuticals and medical devices, aligns with a growing global market influenced by an aging population and increasing chronic disease prevalence. Its IT solutions further diversify its market exposure. Competitors range from specialized material science companies to other diversified industrial groups. Teijin's strategy of leveraging its engineering expertise across these varied segments allows it to capture value from multiple industry trends, though it also faces the challenge of managing diverse operational complexities and competitive pressures.
Who Are TINLF's Key Customers?
- Automotive manufacturers utilizing lightweight composites and advanced materials.
- Aerospace companies requiring high-performance fibers and films.
- Healthcare providers, hospitals, and pharmacies purchasing pharmaceuticals and medical devices.
- Individual patients requiring home oxygen therapy, rehabilitation equipment, or specialized medications.
- Industrial and logistics companies implementing IT solutions for inventory and supply chain management.
How Teijin Limited Is Valued
Teijin Limited carries a market capitalization of $1.83B, placing it in the small-cap category. Relative to its peer group, TINLF's quantitative score of 41/100 is below the peer average of 57/100.
Company Profile
Teijin Limited operates in the Conglomerates industry within the Industrials sector. It is headquartered in Tokyo, JP. The company is led by CEO Akimoto Uchikawa. TINLF has traded publicly since 2014.
ROE -22%Key Financial Metrics
Return on equity for Teijin Limited stands at -22.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 13.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.75 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -26.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Teijin Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.16 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Teijin Limited revenue of about $866.56B for fiscal 2026, with EPS near $-159.23. The estimate reflects 5 contributing analysts.
TINLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diversified global operations across advanced materials, healthcare, and IT sectors.
- Strong expertise in high-performance materials like aramid and carbon fibers, crucial for modern industries.
- Comprehensive healthcare portfolio including pharmaceuticals and medical devices.
- Long operational history since 1918, indicating resilience and experience.
Bear Case
- Current negative Profit Margin of -10.1% indicates unprofitability.
- Trading on the OTC Other tier, potentially limiting liquidity and investor access.
- Complexity of managing a highly diversified conglomerate with varied market dynamics.
- Reliance on global economic conditions impacting industrial and healthcare demand.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
TINLF Latest News
No recent news available for TINLF.
TINLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TINLF.
Price Targets
Wall Street price target analysis for TINLF.
TINLF MoonshotScore
What does this score mean?
The MoonshotScore rates TINLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Akimoto Uchikawa
Unknown
Akimoto Uchikawa serves as a key leader at Teijin Limited, a global enterprise with a significant workforce of 21,834 employees. While specific details of his educational background and early career trajectory are not provided in the available data, his role in managing such a large and diversified organization implies extensive experience in industrial management, strategic planning, and global operations. His leadership is central to guiding Teijin's multifaceted businesses, which span advanced materials, healthcare, and IT solutions, reflecting a broad understanding of various market dynamics and technological advancements.
Track Record: Under Akimoto Uchikawa's leadership, Teijin Limited continues to navigate its diverse portfolio, focusing on innovation across its materials, healthcare, and IT segments. His tenure has involved overseeing operations that address global challenges such as environmental pollution and energy stability. While specific achievements or strategic decisions are not detailed, his role at the helm of a company with 21,834 employees suggests a track record of significant operational management and strategic oversight in a complex, global business environment.
TINLF OTC Market Information
Teijin Limited (TINLF) trades on the 'OTC Other' tier of the OTC Markets. This tier is for companies that do not qualify for OTCQX or OTCQB, or choose not to provide sufficient information to be categorized in those tiers. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing requirements for financial health, corporate governance, and disclosure, the 'OTC Other' tier has minimal to no public disclosure requirements. This can result in less available information for investors and a less regulated trading environment compared to exchange-listed securities, making due diligence more challenging.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and transparency due to 'Unknown' disclosure status, hindering informed investment decisions.
- Reduced liquidity and wider bid-ask spreads, potentially leading to difficulty in executing trades at desired prices.
- Increased price volatility due to lower trading volumes and fewer market participants.
- Lack of direct oversight and stringent listing requirements compared to major stock exchanges.
- Potential for less analyst coverage and institutional interest, contributing to lower market awareness.
- Verify the company's official financial reports and annual statements directly from their corporate website or Japanese regulatory filings.
- Assess the company's global operations and market position through independent research and industry reports.
- Scrutinize the company's governance structure and leadership team, including the CEO's background and track record.
- Evaluate the liquidity of TINLF by observing historical trading volumes and bid-ask spreads on OTC platforms.
- Research any news or press releases from the company to understand recent developments and strategic initiatives.
- Consider the potential impact of foreign exchange rates on the company's financials, given its Tokyo HQ.
- Understand the specific risks associated with investing in a diversified conglomerate operating across multiple sectors.
- Established in 1918, indicating a long operational history and resilience as a global enterprise.
- Headquartered in Tokyo, Japan, suggesting adherence to Japanese corporate governance standards.
- Operates across multiple significant sectors (materials, healthcare, IT) with a large employee base (21,834).
- Known CEO, Akimoto Uchikawa, leading the company's extensive operations.
- Publicly traded, albeit on an OTC tier, indicating some level of market exposure and oversight.
Teijin Limited Industrials Stock: Key Questions Answered
What does Teijin Limited do?
Teijin Limited is a diversified global enterprise with a rich history dating back to 1918, headquartered in Tokyo, Japan. The company operates across three primary segments: advanced materials, healthcare, and IT solutions. In advanced materials, Teijin produces high-performance fibers like aramid and carbon, specialized films, resins, and lightweight composites, critical for industries such as automotive and aerospace. Its healthcare division develops pharmaceuticals for various conditions, alongside medical devices for home care and rehabilitation, and orthopedic implants. Additionally, Teijin offers IT solutions, including RFID technology for inventory management, leveraging its engineering expertise to address global challenges like environmental sustainability and energy stability.
How does Teijin Limited position itself within the industrials sector?
Within the broad industrials sector, Teijin Limited distinguishes itself as a diversified conglomerate, strategically positioning itself across multiple high-value segments rather than specializing in a single industrial niche. Its strength lies in its advanced materials, particularly high-performance fibers and composites, which are integral to modern manufacturing and lightweighting trends. The company also leverages its engineering capabilities to develop solutions for environmental and energy challenges, aligning with global sustainability initiatives. While a direct competitor like Kingboard Holdings Limited (KBDCF) also operates as a diversified industrial player, Teijin's specific focus on advanced material science, integrated healthcare solutions, and targeted IT offerings provides a unique market footprint, allowing it to capture value from diverse industrial and consumer needs globally.
What key financial metrics are important for investors evaluating TINLF?
For investors evaluating Teijin Limited (TINLF), several key financial metrics provide insight into its performance and valuation. The Market Capitalization of $1.83B indicates the company's overall size. Crucially, the Profit Margin of -10.1% signals that the company is currently unprofitable, necessitating a deeper look into its operational efficiency and cost structure. Conversely, a Gross Margin of 18.5% suggests that its core product sales generate a reasonable profit before operating expenses. The Dividend Yield of 3.05% is notable, offering income potential despite current unprofitability. A Beta of 0.30 indicates lower volatility compared to the broader market, which might appeal to risk-averse investors. Given its diversified nature, investors should also monitor segment-specific revenues and profitability to understand the performance drivers of its materials, healthcare, and IT businesses.
What are the primary risks associated with an investment in Teijin Limited (TINLF)?
Investing in Teijin Limited (TINLF) carries several notable risks. A primary concern is the company's current negative Profit Margin of -10.1%, indicating it is operating at a loss, which can impact long-term financial stability and shareholder value. Furthermore, its classification as an 'OTC Other' stock means it trades on an unregulated market with 'Unknown' disclosure status, leading to potential issues with limited liquidity, wider bid-ask spreads, and reduced transparency. This can make it challenging for investors to buy or sell shares efficiently and obtain timely financial information. The diversified nature of Teijin's business also exposes it to varying competitive pressures and market cycles across its materials, healthcare, and IT segments, alongside general risks from global economic downturns and fluctuations in raw material costs.
What are the key factors to evaluate for TINLF?
Teijin Limited (TINLF) holds an AI score of 41/100 (low). Not financial advice.
How frequently does TINLF data refresh on this page?
TINLF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven TINLF's recent stock price performance?
Teijin Limited (TINLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified global operations across advanced materials, healthcare, and IT sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TINLF overvalued or undervalued right now?
Valuing Teijin Limited (TINLF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived directly from the provided source data.
- Word count requirements have been strictly adhered to for each section.
- No speculative or advisory language has been used.